November is Epilepsy Awareness month. Neurotechnologies are emerging to improve diagnoses and treatments for people living with epilepsy. Here we highlight some of the available modalities and what is in the pipeline of development.

Image for post
Image for post
Image by Gerd Altmann from Pixabay

Epilepsies are a spectrum of brain disorders ranging in severity. In epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions, and behavior. This change in neuronal activity can also cause convulsions, muscle spasms, and loss of consciousness. Epilepsies also accompany several types of seizures. Anything that disturbs the normal pattern of neuron activity from illness to brain damage to abnormal brain development can lead to seizures. Epilepsy may develop because of an abnormality in brain wiring, an imbalance of nerve signaling chemicals called neurotransmitters, changes in important features of brain cells called channels, or some combination of these and other factors. Having a single seizure as the result of a high fever (called febrile seizure) or head injury does not necessarily mean that a person has epilepsy. …


For so long the standard of care for Attention Deficit Hyperactivity Disorder (ADHD) has been oral medications, but they are plagued by side effects and dosing challenges. Today, there is a growing pool of scientific and clinical evidence to support neurotechnology devices as an alternative to medications. Some devices are emerging from technical laboratories and others are further along the development spectrum to have regulatory approval or clearance. These technologies may be overlooked under the large umbrella of the pharmaceutical giants. Here, we shine a light on these technology alternatives.

Image for post
Image for post
Image by Daryl Bambic from Pixabay

The American Psychiatric Association estimates that 9.5 percent of children and 4.4 percent of adults in the U.S. have been diagnosed with ADHD. The worldwide prevalence is slightly higher at 7 to 12 percent. For children ages 4 to 17 in the U.S. approximately 11 percent have the condition, which equates to about 6.4 million children. The condition can be diagnosed in a wide age range including adolescents and adults. It is highly prevalent among males. According to the ADHD Institute, symptoms can be impulsiveness or inattention, the condition often arises alongside other psychiatric conditions such as anxiety disorders or depression. …


Neurotechnology, the use of medical electronics on the human nervous system, is offering new options for people living with neurological conditions, enhancing diagnoses and aiding in human performance. Let’s take a look at what made headlines over the month of September 2020. These headlines address technical advancements, changes in access and expanding applications of current technologies.

Image for post
Image for post
Image by kalhh from Pixabay

Technology and Access Developments

  • Those living with obstructive sleep apnea have expanded access to a hypoglossal nerve stimulation device from Inspire Medical Systems. Humana recently announced they will cover the device.
  • Theranica Bio-Electronics Ltd. gained CE Mark approval for their Nerivio device, a non-invasive, smartphone-controlled device for the treatment of migraine headaches. …

You or someone you care about has sustained a spinal cord injury (SCI). You have heard that there are many advances and research occurring in the treatment and management of spinal cord injury but it is hard to decipher the facts from the hype. Neurotech Network is dedicated to providing unbiased information about neurotechnology, a field that offers technical devices and therapies for persons living with neurological conditions like SCI. This will provide some of the broad categories and what they include along with the latest research and links to the device directory. …


Image for post
Image for post

Neurotechnology, the use of medical electronics on the human nervous system, is offering new options for people living with various conditions, enhancing diagnoses and aiding in human performance. Let’s take a look at what made headlines over the month of August 2020. These headlines address technical advancements, changes in access and expanding applications of current technologies.

Technology and Access Developments

  • A new study suggestions the use of ultrasound to detect echointensity of muscles may be a tool to diagnose amyotrophic lateral sclerosis (ALS). The study was published in the Journal Muscle & Nerve.
  • More evidence was published to help those living with treatment-resistant depression. A recently published study in JAMA shows magnetic seizure therapy can help reduce overall remission rate from suicidality by 47.8%. …

August is National Wellness Month in the United States. During this time of a global pandemic and social distancing, the pursuit of wellness has surfaced as many of us around the world have been altering to a new “normal”. What is wellness? Can some neurotech aid in that process? This month we will explore the elements of wellness, neurotechnology applications and some additional educational resources.

What is wellness?

Wellness is often confused with well-being, but they are related. The National Center for Complementary and Integrative Health within the National Institutes of Health views wellness as a multi-dimensional paradigm of pursuit and well-being is defined as individual dimensions within that paradigm such as emotional well-being and physical well-being. …


Image for post
Image for post

Neurotechnology, the use of medical electronics on the human nervous system, is offering new options for people living with various conditions, enhancing diagnoses and aiding in human performance. These developments could have or will have an impact on us. Let’s take a look at what made headlines over the month of July 2020. These headlines address technical advancements, changes in access and expanding applications of current technologies.

Technology and Access Developments

  • Non-invasive vagus nerve stimulation offered by electroCore, Inc. received FDA Emergency Use Authorization to treat asthma exacerbations in people who have known or suspected COVID19.
  • Symptoms of COVID19 can linger. Lungpacer Medical, Inc. implanted their first patient who recovered from COVID19 but still has difficulty breathing independently. …

Image for post
Image for post

North America is now four months into the pandemic. But the world of neurotechnology keeps moving. These developments could have or will have an impact on people living with neurological conditions. Let’s take a look at what made headlines over the month of June 2020.

These headlines address technical advancements, changes in access and expanding applications of current technologies.

The brain sensing revolution continues. Medtronic receives FDA approval for its Percept deep brain stimulation system with BrainSense technology. It has the ability to both sense brain signals and stimulation for those living with Parkinson’s disease.

Epineuron Technologies received FDA Breakthrough device status for their regeneration device for permanent nerve damage. …


Post Traumatic Stress. The condition came to light when members of our military returning from the “theatre” of war and they were diagnosed with a distinct syndrome which is now recognized as a medical condition. It does not mean that it is anything new. For decades it was called shell shock or combat fatigue. Post-Traumatic Stress is not just for military veterans. Civilians live with the condition too. …


Just over 7 years ago the U.S. launched the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, an innovative effort to explore, develop and treat conditions of the human brain. Since then there has been about $1.3 billion dedicated through the National Institutes of Health to develop new tools, diagnostics and treatments for conditions of the brain and central nervous system. Today, there is a consortium of brain research initiatives around the world to build a collective understanding of this precious human organ. Conditions such as Alzheimer’s disease and dementia plague our aging population and is now migrating to younger and younger adults. June is Alzheimer’s disease awareness month. …

Jen French

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store